Rituximab used as a single agent for autoimmune hemolytic anemia (AIHA) in treatment naive chronic lymphocytic leukemia (CLL) patients induces also significant disease response without toxicity
HAEMATOLOGICA(2017)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要